Skip to main navigation menu Skip to main content Skip to site footer

Author reply to technical comment

Vol. 150 No. 2122 (2020)

Reply to comment on: Mumme M, et al. Tissue engineering for paediatric patients. Swiss Med Wkly. 2019.149.w20032

  • Marcus Mumme
  • Anke Wixmerten
  • Ivan Martin
Cite this as:
Swiss Med Wkly. 2020;150:w20240


  1. Rose K, Grant-Kels JM, Neubauer D, Fumi L. Comment on: Mumme M, et al. Tissue engineering for paediatric patients. Swiss Med Wkly. 2020;150:w20239. doi:.
  2. Boeyer ME, Sherwood RJ, Deroche CB, Duren DL. Early Maturity as the New Normal: A Century-long Study of Bone Age. Clin Orthop Relat Res. 2018;476(11):2112–22. doi:.
  3. Gudas R, Gudaite A, Pocius A, Gudiene A, Cekanauskas E, Monastyreckiene E, et al. Ten-year follow-up of a prospective, randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint of athletes. Am J Sports Med. 2012;40(11):2499–508. Published online September 28, 2012. doi:.
  4. Niemeyer P, Albrecht D, Andereya S, Angele P, Ateschrang A, Aurich M, et al. Autologous chondrocyte implantation (ACI) for cartilage defects of the knee: A guideline by the working group “Clinical Tissue Regeneration” of the German Society of Orthopaedics and Trauma (DGOU). Knee. 2016;23(3):426–35. Published online March 3, 2016. doi:.
  5. Salzmann GM, Sah BR, Schmal H, Niemeyer P, Sudkamp NP. Microfracture for treatment of knee cartilage defects in children and adolescents. Pediatr Rep. 2012;4(2):e21. doi:.

Most read articles by the same author(s)